Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 961.40
-25.80 (-2.61%)
At close: Mar 23, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 519.02 billion as of March 23, 2026. Its market cap has increased by 82.01% in one year.
Market Cap
519.02B
Enterprise Value
541.78B
Revenue
67.22B
Ranking
n/a
PE Ratio
61.59
Stock Price
961.40
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 519.02B, an increase of 994.10%. That is a compound annual growth rate of 29.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 519.02B | -13.23% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.62T |
| Cipla | 1.01T |
| Zydus Lifesciences | 896.05B |
| Mankind Pharma | 825.66B |
| Aurobindo Pharma | 750.05B |
| Alkem Laboratories | 628.61B |
| Glenmark Pharmaceuticals | 615.23B |
| Ipca Laboratories | 391.95B |